Showing results (31-40 of 164) with videos related to
Sort By:
Pageof 17
Psychopharmacology Bulletin|January 1, 1993
Systematic dosage reduction in treatment-resistant schizophrenic patientsT Van Putten, B D Marshall, R Liberman, et al.Hospital & Community Psychiatry|February 1, 1978
Drug refusal in schizophrenia: causes and prescribing hintsT Van PuttenPsychopharmacology|January 1, 1987
The sulfoxidation of fluphenazine in schizophrenic patients maintained on fluphenazine decanoateK K Midha, J W Hubbard, S R Marder, et al.Archives of General Psychiatry|April 1, 1994
Fluphenazine vs placebo supplementation for prodromal signs of relapse in schizophreniaS R Marder, W C Wirshing, T Van Putten, et al.Psychopharmacology Bulletin|January 1, 1990
Fluphenazine plasma levels and clinical responseS R Marder, T Van Putten, M Aravagiri, et al.The American Journal of Psychiatry|May 1, 1994
Optimal drug and behavior therapy for treatment-refractory schizophrenic patientsR P Liberman, T Van Putten, B D Marshall, et al.The British Journal of Psychiatry : the Journal of Mental Science|May 1, 1991
Plasma levels of fluphenazine in patients receiving fluphenazine decanoate. Relationship to clinical responseS R Marder, K K Midha, T Van Putten, et al.Psychopharmacology|January 1, 1986
Fluphenazine plasma levels in patients receiving low and conventional doses of fluphenazine decanoateS R Marder, E M Hawes, T Van Putten, et al.The Journal of Nervous and Mental Disease|March 1, 1977
Lithium carbonate in personality disorders: a case of hysteriaT van Putten, J AlbanTherapeutic Drug Monitoring|June 1, 1993
Clinical perspectives of some neuroleptics through development and application of their assaysK K Midha, S R Marder, T J Jaworski, et al.Pageof 17